Menarini Silicon Biosystems, Bologna, Italy, has signed a nonexclusive distribution agreement to begin selling a rapid antibody detection kit that can help determine if someone has been previously infected with the novel coronavirus, SARS-CoV-2.
The Covid-19 IgG/IgM Rapid Test Cassette, manufactured by Healgen Scientific, Houston, is now available for use in the United States under an FDA emergency use authorization. The test is also available in Europe through A. Menarini Diagnostics.
“We are proud to utilize our distribution channels, both in the United States and abroad, to increase access to technology that will provide clinicians and public health experts with more information to address this global health crisis,” says Fabio Piazzalunga, president of Menarini Silicon Biosystems.
Healgen’s Covid-19 IgG/IgM Rapid Test Cassette detects two types of antibodies, immunoglobulin G (IgG) and immunoglobulin M (IgM), in just 10 minutes. To use the test, healthcare workers place a small sample of serum or plasma or one drop of blood on a test cassette. Molecules in the test kit bind to any antibodies specific to the virus. If antibodies are present, a positive result will appear in the cartridge. Currently, the test is authorized for use in laboratories certified to perform “moderate or high complexity tests.”
For more information, visit Menarini Silicon Biosystems.